Zydus' Generic Erythromycin Receives Approval in the U.S.
Enforcement Report - Week of January 25, 2023
Enforcement Report - Week of February 23, 2022
Enforcement Report - Week of September 1, 2021
Enforcement Report - Week of July 28, 2021
The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of 41 KSMs/DIs/APIs.
Orange`s Generic Erythromycin Receives Approval in USA
Teva Pharms USA`s Generic Erythromycin Receives Approval In US
Torrent Pharms Generic Erythromycin Receives Approval in US
MEHTA API Fails EDQM Inspection